Tetra Bio Pharma (TSXV:TBP)
Historical Stock Chart
1 Year : From Jul 2018 to Jul 2019
ORLEANS, ON, Oct. 15, 2018 /CNW/ -
Dr. Guy Chamberland, M.Sc., Ph.D.,
Interim CEO and Chief Scientific Officer, Tetra Bio-Pharma
Recent live and pre-taped media experience:
- Business of Cannabis
- Tetra Bio-Pharma is a global leader in the discovery and development of cannabis and cannabinoid drugs. www.tetrabiopharma.com
- Tetra is the only company in North America working with Health Canada and the FDA on clinical trial programs that lead to prescription cannabis drugs.
- Dr. Chamberland has 22 + years of experience in drug development expertise in regulatory affairs, and the development and management of clinical research protocols and clinical studies for botanical medicines.
- He is fluently bilingual and a recognized expert in botanical medicine, publishing, lecturing and delivering continuing education workshops on the use of plants in the treatment of such areas as pain, anxiety, insomnia, and wound healing.
- He is Professor of Botanical Medicine and Principles of clinical research at the Ecole d'Enseignement Superieur de Naturopathie du Quebec (EESNQ).
- Is there a way to consume recreational cannabis safely?
- If you have a health condition and plan to use recreational cannabis – what are the risks?
- Should we expect an increase in ER visits after October 17 and why?
- Should we worry about the lack of scientific evidence to prove the safety and efficacy of cannabis?
- Will doctors, regulators like Health Canada and bodies like the Canadian Medical Association ever approve cannabis use?
- How far is Canada/the US away from having cannabis in pharmacies, and covered by insurance?
An excellent speaker, Dr. Chamberland is available for media appearances in the Montreal/Southern Ontario region.
SOURCE Tetra Bio-Pharma